Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

NCT04798690 · tracked via the Priya Life Science South Korea tracker

Sponsor

Dong-A ST Co., Ltd

Phase

Observational

Started

2021-02-08

Last updated

2026-07-21

Condition(s) studied

Growth Hormone DeficiencyIdiopathic Short StatureTurner SyndromeSmall for Gestational Age

Study summary

This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.

Eligibility

Sex

ALL

Min age

2 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA) * Children who has official height record at least 6 months prior Exclusion Criteria: * Children with Epiphyseal closure

Primary outcome measure(s)

Long term safety assessed through the adverse events — Up to 2 years after epiphyseal closure
Number of occurrence of treatment-related adverse events

Trial sites (1)

Facility	City	Region	Status
Yonsei University Health System, Severance Hospital	Seoul	Seodaemun-gu	Recruiting

More Dong-A ST Co., Ltd. trials in South Korea

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control Starting soon

Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects Starting soon

A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia Recruiting

Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control Active, not recruiting

Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors Recruiting

Other trials for the same condition

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders Recruiting

Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children Recruiting

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature Recruiting

A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9 Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04798690 on ClinicalTrials.gov ↗ ← All trials in South Korea